Effect of poly(ethylene glycol) content and formulation parameters on particulate properties and intraperitoneal delivery of insulin from PLGA nanoparticles prepared using the double-emulsion evaporation procedure
- 6 March 2017
- journal article
- research article
- Published by Taylor & Francis in Pharmaceutical Development and Technology
- Vol. 23 (4) , 370-381
Abstract
Context: Size, encapsulation efficiency and stability affect the sustained release from nanoparticles containing protein-type drugs. Objectives: Insulin was used to evaluate effects of formulation parameters on minimizing diameter, maximizing encapsulation efficiency and preserving blood glucose control following intraperitoneal (IP) administration. Methods: Homogenization or sonication was used to incorporate insulin into poly(D,L-lactic-co-glycolic acid) (PLGA) nanoparticles with increasing poly(ethylene glycol) (PEG) content. Effects of polymer type, insulin/polymer loading ratio and stabilizer in the internal aqueous phase on physicochemical characteristics of NP, in vitro release and stability of encapsulated insulin were investigated. Entrapment efficiency and release were assessed by radioimmunoassay and bicinconnic acid protein assay, and stability was evaluated using SDS-PAGE. Bioactivity of insulin was assessed in streptozotocin-induced, insulin-deficient Type I diabetic mice. Results: Increasing polymeric PEG increased encapsulation efficiency, while the absence of internal stabilizer improved encapsulation and minimized burst release kinetics. Homogenization was shown to be superior to sonication, with NP fabricated from 10% PEG–PLGA having higher insulin encapsulation, lower burst release and better stability. Insulin-loaded NP maintained normoglycaemia for 24 h in diabetic mice following a single bolus, with no evidence of hypoglycemia. Conclusions: Insulin-loaded NP prepared from 10% PEG–PLGA possessed therapeutically useful encapsulation and release kinetics when delivered by the IP route.Keywords
This publication has 40 references indexed in Scilit:
- PEGylated-PLGA microparticles containing VEGF for long term drug deliveryInternational Journal of Pharmaceutics, 2013
- Effect of cryoprotectants on the porosity and stability of insulin-loaded PLGA nanoparticles after freeze-dryingBiomatter, 2012
- Delivery of Therapeutic ProteinsJournal of Pharmaceutical Sciences, 2010
- Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(d, l-lactide) (PLA) based nanoparticlesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2010
- High loading efficiency and tunable release of plasmid DNA encapsulated in submicron particles fabricated from PLGA conjugated with poly-L-lysineJournal of Controlled Release, 2008
- Preparation, in vitro release, in vivo absorption and biocompatibility studies of insulin-loaded microspheres in rabbitsAAPS PharmSciTech, 2005
- Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation methodBiomaterials, 2001
- Biodegradable poly(d,l-lactic acid)-poly(ethylene glycol)-monomethyl ether diblock copolymers: structures and surface properties relevant to their use as biomaterialsBiomaterials, 2000
- Determination of poly(vinyl alcohol) via its complex with boric acid and iodineAnalytica Chimica Acta, 1979
- Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogenJournal of Clinical Pathology, 1969